Biosimilars LATAM Regulations

16th & 17th November 2017,
Hilton Mexico City Santa Fe

Biosimilars LATAM Regulations

16th & 17th November 2017, Hilton Mexico City Santa Fe

Comment on twitter #JL_biosimilars

bio-guru-vision.svg
Discussions
New guidelines in Europe. The Latam’s reference region update.
bio-network.svg
Updates
All stakeholders in one place
bio-hot-toics.svg
Advices
Ask HCPs and Patients how to develop your strategies
bio-new-markets.svg
Fresh views
C-level executive outlook on the future of Biosimilars in LATAM

Click on the image to play

Summary

The regulation of similar bio-therapeutic products varies widely among the different Latin American countries. While some of them are yet to introduce their own regulation, others — like Brazil and Mexico — have opened ways to cheaper, complex and safe biological treatment for patients. However, many things need improving and a lot of experience is still necessary to develop a mature LATAM Biosimilars Market.

Biosimilars Forum 2017 is a unique and effective meeting point to share the information and experience Latin America’s Pharmaceutical Industry needs to develop a dynamic and thriving biosimilars market.

Join us in Mexico and trigger a quantum leap in Latin American Healthcare!

Why to attend?

  • Get the latest regulatory updates in Mexico, Colombia, Brazil, Argentina and Peru and understand the ambitious plans to approve biosimilars in Latam.
  • Learn from real case studies and first-hand experience in tackling industry challenges, as well as in developing and registering biosimilars.
  • Identify market opportunities
  • Gather the know-how and practical knowledge you need to improve your business strategies.
  • Enhance your visibility within the industry by taking part in open discussions.

Who will you meet?

CEOs / COOs / Directors / VPs / Bio-technologists / Managing Directors / Managers and Specialists in:

  • Biosimilars, Biobetters, Biotechnology, Biotherapeutics, Analytical science, Regulatory compliance, Quality control, Clinical immunology, Scientific affairs, Pharmacology, Pharmacovigilance

Government Institutions, Health Care Professionals and Patients Associations.

Speakers

Javier Coindreau

Javier Coindreau

Pfizer | USA | Global VP Medical Affairs Read More
Jaime Uribe

Jaime Uribe

Probiomed | CEO | Mexico Read More
Julio Sánchez y Tépoz

Julio Sánchez y Tépoz

Cofepris, México | Comisionado Federal Read More
Mafalda Hurtado

Mafalda Hurtado

Previously: AstraZeneca | Mexico | Country Business Unit Director - Oncology & Immunology Read More
Gustavo Peralta

Gustavo Peralta

Ferring Pharmaceuticals | Mexico | Regulatory Affairs & Pharmacovigilance Director Read More
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6

Program

1st day

Regulations Update

Regulations Update in Colombia, Brazil, Argentina and Peru by experts.

Discussion with regulatory experts
Update on clinical trial designs for biosimilars
Delivery device in Biosimilars: risks and key lessons learned through experience.
Synthetic Biology and Systems Biology: Personalized Medicine and the Future of Biosimilars.
Case Study: The Viability of Investing into Technological Platforms for Manufacturing Biosimilars in Mexico.
Complete platforms for the development of Biosimilars. Strategies and innovation with a holistic vision.

2nd day

HCP & Patients Advise on How to improve the access of biosimilars.

Most HCPs and patients lack information on Biosimilar medication. Why does this matter and what can be done?

Characterizing Biological and Physicochemical Challenges of Biosimilars in Mexico.
Legal and Compliance Environment for Biosimilars in Latin America.
Case Study: Profiting from Biosimilars.
Best Practice:
Clinical Research and the Registration of Biosimilars
Expert Panel

Speaking Companies

Speaking Companies

Speaking Companies

Speaking Companies

Speaking Companies

Speaking Companies

Association Partner

Association Partner

Association Partner

Association Partner

Association Partner

Association Partner

Association Partner

Association Partner

Media Partner

Association Partner

Media Partner

Media Partner of Jack Leckerman

Media Partner

Media Partner of Jack Leckerman

Media Partner

Media Partner

Keep me updated

About "Jack Leckerman"

Jack Leckerman Company has been established as a business intelligence event services and the promotion of global summits, strategic conferences, open forums and professional training.

©2017 Jack Leckerman. All Rights Reserved. Designed By

Search